We are proud to announce that Massive Bio has been recognized as the second most innovative company in Türkiye for 2024 in Fast Company's Most Innovative Companies rankings! 🎉✨ This achievement reflects our unwavering commitment to combining cutting-edge technology with a patient-first approach, ensuring that everyone, everywhere, has access to clinical trials. We dedicate this honor to our incredible team, partners, and the patients who inspire us every day. Together, we continue to innovate and break barriers in cancer care and clinical trial accessibility. 🌍 Thank you for believing in our mission! Here's to more milestones ahead. #Innovation #ClinicalTrials #CancerCare #TopInnovativeCompanies Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu
Massive Bio
Hospitals and Health Care
An AI-driven platform connecting cancer patients to bio-pharmaceutical clinical trials.
About us
Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers' experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.
- Website
-
https://linktr.ee/massivebio_
External link for Massive Bio
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- Istanbul
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Targeted cancer therapies, Cancer genomics, Tumor profiling technologies, Clinical trial selection, Second Opinion, Cancer Treatment, precision oncology, personalized cancer treatment options, Oncology, Cancer Care, and Cancer Research
Locations
-
Primary
İçerenköy Mah. Umut Sok. Quick Tower Sitesi No:10-12/55
Ataşehir
Istanbul, 34752, TR
Employees at Massive Bio
Updates
-
At Massive Bio, we’re committed to connecting more people with clinical trials, as highlighted during our recent round table in Madrid. Led by Dersu Giritlioglu, Senior Product Manager for Physician Experience and Clinical Operations, and Gisela Saladino, Account Manager for Spain, this event brought together physicians to discuss patient conditions, trial eligibility, and the evolving needs of clinical operations. Through engaging discussions and collaboration, we had the opportunity to showcase our Clinical Network, gather valuable insights, and strengthen relationships within the medical community. Events like these highlight our commitment to innovation and improving patient outcomes worldwide. Thank you to everyone who contributed to making this visit impactful and meaningful! #MassiveBio #ClinicalTrials #GlobalHealthcare #Collaboration Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu
-
Happy New Year from Massive Bio! 🎆✨ As we welcome the new year, we wish you and your loved ones a season filled with joy, good health, and new opportunities. Thank you for being a part of our journey. Here's to a bright and meaningful 2025! 🌟 #HappyNewYear #MassiveBio #NewBeginnings
-
🎄 Finding Hope This Holiday Season 🎄 Sometimes, the most meaningful moments come from the simplest gestures. This holiday season, a single connection could lead to life-changing opportunities. At Massive Bio, we support patients and their families in exploring #clinicaltrials, offering renewed possibilities and comfort during their journey. ✨ Give yourself or your loved ones the gift of possibilities—because #hope begins with taking that next step. Learn more: massivebio.com #HopeForTheHolidays #MassiveBio #CancerSupport #ClinicalTrials Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu
-
✨ Celebrating the spirit of togetherness as we wrap up an incredible year! ✨ As the holiday season fills our hearts with joy, we reflect on the smiles, memories, and connections that made 2024 unforgettable. Massive Bio wishes you and your loved ones a Merry Christmas and #HappyNewYear! 🎄🎉 Cheers to an even brighter and more successful 2025! 🎆 Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu
-
🌟 In 2024, we transformed access to clinical trials, opening doors for patients and families worldwide. This year showed how the blend of innovation and compassion can make a real difference in people's lives. As we look to 2025, our mission is to amplify these efforts—connecting with more patients, eliminating barriers, and equipping individuals with the resources they need to navigate their journeys. Thank you for being part of this journey. 💙 Together, we can accomplish extraordinary milestones. ✨ Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu
-
🚨 Today’s the Day! Don’t Miss Our Inspiring Webinar! 🚨 Join us TODAY, December 23rd, for our final webinar of the year. 💻 Aleksandra Wiederek will share her courageous breast cancer journey, and Marta Halke-Markiewicz, our Account Manager for Poland & Germany, will discuss: ✅ The challenges patients face ✅ The power of support systems ✅ How personalized solutions can make a difference ⏰ Time: 11:00 AM ET | 17:00 CET 🌐 Language: Polish 👉 There’s still time to register: https://lnkd.in/dWvr2y2S This is your chance to join a meaningful conversation and end the year with hope and inspiration. See you soon! 🌟 __________________________________________________________________________ 🚨 To już dziś! Nie przegap naszego inspirującego webinaru! 🚨 Dołącz do nas DZISIAJ, 23 grudnia, na naszym ostatnim webinarze w tym roku. 💻 Aleksandra Wiederek podzieli się swoją odważną historią walki z rakiem piersi, a Marta Halke-Markiewicz nasza Menedżerka ds. Kluczowych Klientów na Polskę i Niemcy, porozmawia o: ✅ Wyzwaniach, przed którymi stają pacjenci ✅ Sile systemów wsparcia ✅ Jak spersonalizowane rozwiązania mogą odmieniać sytuację ⏰ Czas: 11:00 AM ET | 17:00 CET 🌐 Język: Polski 👉 Zarejestruj się tutaj: https://lnkd.in/dWvr2y2S To Twoja szansa na wzięcie udziału w ważnej rozmowie i zakończenie roku z nadzieją i inspiracją. Do zobaczenia! 🌟 Selin Kurnaz, PhD, Arturo LoAIza-Bonilla MD, Çağatay M. Çulcuoğlu
-
We’re proud to have our Co-Founder and Chief Medical Officer, Dr. Arturo LoAIza-Bonilla MD, leading the charge in this transformative journey. His techno-optimistic vision for cancer care in 2034, featured in Stratégies Magazine, inspires us to break barriers and drive innovation every day. 🚀 #CancerCare #AI #ClinicalTrials #CancerResearch #DCT
Co-Founder, Massive Bio | Chief of Hematology and Oncology, SLUHN | WebMD Medscape Columnist | AI in Oncology | 40 under 40 in Cancer | OpenAI Forum | HealthTech |
"Imagine a world where every patient, regardless of geography or socioeconomic status, has access to the best treatment options available – a world where a diagnosis does not come with a stigma or an expiration date, but rather with hope and personalized pathways to wellness. AI, coupled with innovative treatment approaches, will continue to drive us toward this vision" - Thank you Strategies Magazine - Next Wave Group for letting me share a techno-optimist view of cancer care in 2034!! St. Luke's University Health Network | Massive Bio | CancerX | Advanced Research Projects Agency for Health (ARPA-H) | MITRE #AI #clinicaltrials #cancerresearch #DCT https://lnkd.in/erWRi26X
-
We are pleased to welcome Alanur U. to the team as the new Operations Manager, Provider Engagement. We look forward to her contributions as she joins us in advancing our global operations. #NewHire #TeamAnnouncement #ProviderEngagement #OperationsManagement
-
At Massive Bio, we believe every patient’s journey is unique and deserves to be heard. Join us for our final webinar of the year featuring Aleksandra Wiederek, who will share her courageous Breast Cancer Journey. Together with Marta Halke-Markiewicz, our Account Manager for Poland & Germany, we’ll discuss the challenges patients face, the power of support systems, and how personalized solutions can make a difference. 📅 Monday, December 23 ⏰ 11:00 AM ET | 17:00 CET The webinar will be held in Polish. Register here: https://lnkd.in/dWvr2y2S __________________________ W Massive Bio wierzymy, że każda podróż pacjenta jest wyjątkowa i zasługuje na wysłuchanie. Dołącz do nas na ostatnim webinarze w tym roku z Aleksandra Wiederek, która podzieli się swoją odważną historią związaną z rakiem piersi. Razem z Marta Halke-Markiewicz, naszą Menedżerką ds. Kluczowych Klientów w Polsce i Niemczech, porozmawiamy o wyzwaniach, przed którymi stają pacjenci, sile systemów wsparcia oraz o tym, jak spersonalizowane rozwiązania mogą odmienić sytuację. 📅 Poniedziałek, 23 grudnia ⏰ 17:00 CET | 11:00 ET Webinar odbędzie się w języku polskim. Zarejestruj się tutaj: https://lnkd.in/dqKq7zcT